PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsBenuvia Therapeutics
Benuvia Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
SyndrosDronabinol2017-03-232028
Vomiting
,
Nausea
,
Anorexia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Aspartame
hypertension
,
ocular hypertension
,
glaucoma
,
open-angle glaucoma
,
cataract
Nabiximols
healthy volunteers/patients
,
hepatic insufficiency
,
marijuana abuse
,
glioblastoma
,
diabetes mellitus
,
autism spectrum disorder
,
sturge-weber syndrome
,
type 2 diabetes mellitus
,
recurrence
,
brain neoplasms
,
cannabis
,
cognitive dysfunction
,
drug resistant epilepsy
,
schizophrenia
,
psychotic disorders
,
mental disorders
,
dyslipidemias
,
fatty liver
,
neuromyelitis optica
,
autistic disorder
,
wounds and injuries
,
pain
,
neoplasms
,
neuralgia
,
peripheral nervous system diseases
,
infantile spasms
,
cancer pain
,
anxiety disorders
,
hyperalgesia
,
rett syndrome
,
spinal cord injuries
,
cerebral palsy
,
post-traumatic stress disorders
,
traumatic stress disorders
,
palliative care
,
postoperative nausea and vomiting
,
postoperative pain
,
anxiety
,
overactive urinary bladder
,
diabetic neuropathies
,
multiple sclerosis
,
sclerosis
,
epilepsy
,
muscle spasticity
,
seizures
,
myoclonic epilepsies
,
lennox gastaut syndrome
,
tuberous sclerosis
,
liver cirrhosis
,
behavior
,
central nervous system diseases
,
brain diseases
,
pregnancy complications
,
pregnancy
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use